BIM
ABBV icon

Bogle Investment Management’s AbbVie ABBV Stock Holding History

Bogle Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-142,741
Closed -$10.9M – 303
2020
Q1 		$10.9M Sell
142,741
-23,000
-14% -$1.96M 1.14% 10
2019
Q4 		$14.7M Sell
165,741
-16,515
-9% -$1.37M 1.37% 4
2019
Q3 		$13.8M Buy
182,256
+13,700
+8% +$939K 1.19% 11
2019
Q2 		$12.3M Buy
168,556
+11,992
+8% +$943K 0.96% 36
2019
Q1 		$12.6M Buy
+156,564
New +$12.8M 0.97% 34
2018
Q3 		– Sell
-126,844
Closed -$11.8M – 264
2018
Q2 		$11.8M Buy
126,844
+4,089
+3% +$399K 0.85% 55
2018
Q1 		$11.6M Buy
+122,755
New +$13.5M 0.87% 48

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bogle Investment Management's ABBV Position: Q2 2020 in Review

Bogle Investment Management sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 142,741 shares — an estimated $10.9M sold.

Bogle Investment Management first reported a position in ABBV in Q1 2018 and held it in 7 quarters. The position peaked at $14.7M in Q4 2019. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Bogle Investment Management reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 142,741 AbbVie shares in Q2 2020, an estimated $10.9M.
  • Bogle Investment Management first reported a position in AbbVie in Q1 2018 and held it in 7 quarters.
  • Bogle Investment Management's AbbVie position peaked at $14.7M in Q4 2019.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.